| Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label … J Hardy, C Baggott, J Fingleton, HK Reddel, RJ Hancox, M Harwood, ... The Lancet 394 (10202), 919-928, 2019 | 264 | 2019 |
| Treatable traits: a new paradigm for 21st century management of chronic airway diseases: Treatable Traits Down Under International Workshop report VM McDonald, J Fingleton, A Agusti, SA Hiles, VL Clark, AE Holland, ... European Respiratory Journal 53 (5), 2019 | 195 | 2019 |
| Predictive value of blood eosinophils and exhaled nitric oxide in adults with mild asthma: a prespecified subgroup analysis of an open-label, parallel-group, randomised … ID Pavord, M Holliday, HK Reddel, I Braithwaite, S Ebmeier, RJ Hancox, ... The Lancet Respiratory Medicine 8 (7), 671-680, 2020 | 100 | 2020 |
| Defining a severe asthma super-responder: findings from a Delphi process JW Upham, C Le Lievre, DJ Jackson, M Masoli, ME Wechsler, DB Price, ... The Journal of Allergy and Clinical Immunology: In Practice 9 (11), 3997-4004, 2021 | 93 | 2021 |
| Treatment responsiveness of phenotypes of symptomatic airways obstruction in adults J Fingleton, J Travers, M Williams, T Charles, D Bowles, R Strik, ... Journal of Allergy and Clinical Immunology 136 (3), 601-609, 2015 | 64 | 2015 |
| Accuracy and precision of transcutaneous carbon dioxide monitoring: a systematic review and meta-analysis A Conway, E Tipton, WH Liu, Z Conway, K Soalheira, J Sutherland, ... Thorax 74 (2), 157-163, 2019 | 59 | 2019 |
| Serum periostin in obstructive airways disease J Fingleton, I Braithwaite, J Travers, D Bowles, R Strik, R Siebers, ... European Respiratory Journal 47 (5), 1383-1391, 2016 | 58 | 2016 |
| Nasal high flow therapy and PtCO2 in stable COPD: A randomized controlled cross‐over trial S McKinstry, J Pilcher, G Bardsley, J Berry, S Van de Hei, I Braithwaite, ... Respirology 23 (4), 378-384, 2018 | 46 | 2018 |
| ICS-formoterol reliever versus ICS and short-acting β2-agonist reliever in asthma: a systematic review and meta-analysis L Hatter, P Bruce, I Braithwaite, M Holliday, J Fingleton, M Weatherall, ... ERJ Open Research 7 (1), 2021 | 44 | 2021 |
| Reference ranges for serum periostin in a population without asthma or chronic obstructive pulmonary disease R Caswell‐Smith, A Hosking, T Cripps, C Holweg, J Matthews, M Holliday, ... Clinical & Experimental Allergy 46 (10), 1303-1314, 2016 | 44 | 2016 |
| Patient preferences for symptom-driven or regular preventer treatment in mild to moderate asthma: findings from the PRACTICAL study, a randomised clinical trial C Baggott, HK Reddel, J Hardy, J Sparks, M Holliday, A Corin, ... European Respiratory Journal 55 (4), 2020 | 38 | 2020 |
| Randomised controlled trial of topical kanuka honey for the treatment of rosacea I Braithwaite, A Hunt, J Riley, J Fingleton, J Kocks, A Corin, C Helm, ... BMJ open 5 (6), e007651, 2015 | 37 | 2015 |
| Type 2 biomarkers and prediction of future exacerbations and lung function decline in adult asthma R Semprini, M Williams, A Semprini, A McDouall, J Fingleton, C Holweg, ... The Journal of Allergy and Clinical Immunology: In Practice 6 (6), 1982-1988. e1, 2018 | 32 | 2018 |
| Treatable traits of chronic airways disease J Fingleton, J Hardy, R Beasley Current opinion in pulmonary medicine 24 (1), 24-31, 2018 | 32 | 2018 |
| Oxygen versus air-driven nebulisers for exacerbations of chronic obstructive pulmonary disease: a randomised controlled trial G Bardsley, J Pilcher, S McKinstry, P Shirtcliffe, J Berry, J Fingleton, ... BMC Pulmonary Medicine 18, 1-9, 2018 | 31 | 2018 |
| Nasal high‐flow therapy compared with non‐invasive ventilation in COPD patients with chronic respiratory failure: A randomized controlled cross‐over trial S McKinstry, J Singer, JP Baarsma, M Weatherall, R Beasley, J Fingleton Respirology 24 (11), 1081-1087, 2019 | 27 | 2019 |
| Randomised controlled trial of topical kanuka honey for the treatment of acne A Semprini, I Braithwaite, A Corin, D Sheahan, C Tofield, C Helm, ... BMJ open 6 (2), e009448, 2016 | 26 | 2016 |
| Towards individualised treatment in COPD J Fingleton, M Weatherall, R Beasley Thorax 66 (5), 363-364, 2011 | 26 | 2011 |
| Change in biomarkers of type-2 inflammation following severe exacerbations of asthma R Semprini, N Shortt, S Ebmeier, A Semprini, R Varughese, CTJ Holweg, ... Thorax 74 (1), 95-98, 2019 | 25 | 2019 |
| Randomized controlled trial of the effect of regular paracetamol on influenza infection S Jefferies, I Braithwaite, S Walker, M Weatherall, L Jennings, M Luck, ... Respirology 21 (2), 370-377, 2016 | 25 | 2016 |
Justin TraversVerified email at huttvalleydhb.org.nz
